A Dose-Response Study of Anticholinesterase Drugs on Contractile and Phosphatidylinositol Responses of Rat Trachea
A Dose-Response Study of Anticholinesterase Drugs on Contractile and Phosphatidylinositol Responses of Rat Trachea
复制标题
抗胆碱酯酶药物对大鼠气管收缩和磷脂酰肌醇反应的剂量反应研究
DOI:
10.1097/00000539-200101000-00020
复制
发表时间:
2001
影响因子:
5.7
通讯作者:
K. Sumikawa
中科院分区:
文献类型:
--
作者:
A. Tsuda;O. Shibata;M. Saito;Shigeru Hashimoto;Shunichiro Iwanaga;T. Makita;K. Sumikawa
We investigated whether anticholinesterase drugs in large doses inhibit muscarinic receptors of airway smooth muscle. In vitro measurements of isometric tension and [3H]inositol monophosphate (IP1) that formed were conducted by using rat tracheal rings or slices. Neostigmine and pyridostigmine caused muscular contraction and IP1 accumulation in small doses (10 &mgr;M and ≤100 &mgr;M, respectively), but they attenuated muscular contraction and IP1 accumulation in larger doses (1000 &mgr;M). Edrophonium did not affect the smooth muscle tone and IP1 levels. Neostigmine, pyridostigmine, and edrophonium attenuated the carbachol (5.5 &mgr;M)-induced smooth muscle contraction and IP1 accumulation, when administered in large doses (1000 &mgr;M). The attenuation of contraction by neostigmine at large doses was not affected by methoctramine, an M2 muscarinic receptor antagonist, but was reversed by washing with fresh Krebs-Henseleit solution. The results suggest that anticholinesterase drugs have dual effects on the tension and phosphatidylinositol responses of rat trachea. Large doses of anticholinesterase drugs cause airway smooth muscle relaxation, which may be seen in patients with myasthenia gravis who have received excessive anticholinesterase therapy. Implications Neostigmine and pyridostigmine, but not edrophonium, have dual effects on the tension and phosphatidylinositol responses of rat trachea. Large doses of anticholinesterase drugs cause airway smooth muscle relaxation, which may be seen in patients with myasthenia gravis who have received excessive anticholinesterase therapy.
DOI:
--
发表时间:
1991
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Lee,NH;el-Fakahany,EE
通讯作者:
el-Fakahany,EE
DOI:
10.1164/ajrccm.157.2.9704074
发表时间:
1998
期刊:
American journal of respiratory and critical care medicine.
影响因子:
--
作者:
Yoshihara,S;Nadel,JA;Figini,M;Emanueli,C;Pradelles,P;Geppetti,P
通讯作者:
Geppetti,P